{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:19:06Z","timestamp":1774361946792,"version":"3.50.1"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Peripheral blood (PB) blast cell count on day 8 of prednisone therapy has been considered one of the strongest predictors of outcome in children with acute lymphoblastic leukemia (ALL). However, little is known about the clinical features and prognostic impact of PB blast cell count at diagnosis in these patients. The aim of this study was to evaluate the relationship between initial PB blast cell count and clinical prognosis of pediatric ALL.<\/jats:p>\n            <jats:p>The study comprised 367 patients with ALL, aged 0 to 14\u200ayears, enrolled and treated using the Chinese Children's Leukemia Group-ALL 2008 protocol between 2011 and 2015. The majority (91.6%) of patients were B-cell precursor ALL (BCP ALL), and 8.4% were T-cell ALL (T-ALL).<\/jats:p>\n            <jats:p>Patients with BCP ALL in the low PB blast cell count group (&lt;1\u200a\u00d7\u200a10<jats:sup>9<\/jats:sup>\/L) had significantly superior survival rates to those in the high count group (\u226530\u200a\u00d7\u200a10<jats:sup>9<\/jats:sup>\/L). In T-ALL, the low count group showed significantly inferior survival rates compared to both the intermediate count group (1\u201329.9\u200a\u00d7\u200a10<jats:sup>9<\/jats:sup>\/L) and high count group. Multivariate analysis revealed that the initial white blood cell count and minimal residual disease at the end of induction therapy were independently predictive of BCP ALL outcome, while risk stratification was shown to be an independent prognostic factor for T-ALL outcome.<\/jats:p>\n            <jats:p>These results indicated that low blast cell count in PB at diagnosis was associated with different clinical outcomes in patients with BCP ALL and T-ALL, although it was not an independent outcome predictor by multivariate analysis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024518","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:05:19Z","timestamp":1611914719000},"page":"e24518","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Clinical features and outcome of pediatric acute lymphoblastic leukemia with low peripheral blood blast cell count at diagnosis"],"prefix":"10.1097","volume":"100","author":[{"given":"Qingkai","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuefang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyun","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0487-1888","authenticated-orcid":false,"given":"Yongmei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S2352-4642(18)30066-X","article-title":"Global efforts toward the cure of childhood acute lymphoblastic leukaemia","volume":"2","author":"Pui","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bjhh.2015.03.009","article-title":"Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival","volume":"37","author":"Lustosa de Sousa","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/1097-0142(19950401)75:7<1684::AID-CNCR2820750720>3.0.CO;2-2","article-title":"Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)","volume":"75","author":"Aric\u00f2","year":"1995","journal-title":"Cancer"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood.V82.2.343.343","article-title":"Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia","volume":"82","author":"Pui","year":"1993","journal-title":"Blood"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"J Clin Oncol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1182\/blood.V96.7.2543","article-title":"New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group report of 343 cases","volume":"96","author":"Schneider","year":"2000","journal-title":"Blood"},{"key":"R8-20250504","first-page":"735","article-title":"Biology and treatment of childhood T-lineage acute lymphoblastic leukemia","volume":"91","author":"Uckun","year":"1998","journal-title":"Blood"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2002-01-0006","article-title":"Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia","volume":"100","author":"Coustan-Smith","year":"2002","journal-title":"Blood"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.2008.000414","article-title":"Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting","volume":"94","author":"Irving","year":"2009","journal-title":"Haematologica"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","article-title":"Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome","volume":"99","author":"Nyvold","year":"2002","journal-title":"Blood"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/leu.2008.324","article-title":"Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction","volume":"23","author":"Ratei","year":"2009","journal-title":"Leukemia"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2006-01-024729","article-title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)","volume":"109","author":"Schultz","year":"2007","journal-title":"Blood"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.leu.2401555","article-title":"Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study","volume":"13","author":"Pullen","year":"1999","journal-title":"Leukemia"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.leukres.2006.08.004","article-title":"Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates","volume":"31","author":"Yanada","year":"2007","journal-title":"Leuk Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","article-title":"Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM86","volume":"84","author":"Reiter","year":"1994","journal-title":"Blood"},{"key":"R18-20250504","first-page":"439","article-title":"Results and significance of six randomized trials in four consecutive ALL-BFM studies","volume":"33","author":"Riehm","year":"1990","journal-title":"Hematol Blood Transfus"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0145-2126(98)00162-3","article-title":"Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM\u201990 protocol: lack of improvement in high-risk group","volume":"23","author":"Sackmann-Muriel","year":"1999","journal-title":"Leuk Res"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.1981.tb02684.x","article-title":"The morphological classification of acute lymphoblastic leukemia: concordance among observers and clinical correlation","volume":"47","author":"Bennett","year":"1981","journal-title":"Br J Haematol"},{"key":"R21-20250504","first-page":"1680","article-title":"A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemia","volume":"20","author":"Hu","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.2147\/OTT.S115257","article-title":"E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol","volume":"9","author":"Hu","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.leu.2402150","article-title":"BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 concerted action investigation of minimal residual disease in acute leukemia: International Standardization and Clinical Evaluation","volume":"15","author":"Lucio","year":"2001","journal-title":"Leukemia"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ijlh.12476","article-title":"Clinical value to quantitate hematogones in Chinese childhood acute lymphoblastic leukemia by flow cytometry analysis","volume":"38","author":"Wang","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.leukres.2018.03.001","article-title":"No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia","volume":"68","author":"Dai","year":"2018","journal-title":"Leuk Res"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1468-0734.2002.00068.x","article-title":"Recent approaches in acute lymphoblastic leukemia in adults","volume":"6","author":"G\u00f6kbuget","year":"2002","journal-title":"Rev Clin Exp Hematol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bjh.12442","article-title":"Predicting relapse risk in childhood acute lymphoblastic leukaemia","volume":"162","author":"Teachey","year":"2013","journal-title":"Br J Haematol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0609.2010.01522.x","article-title":"High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies","volume":"86","author":"Vaitkevi\u010dien\u0117","year":"2011","journal-title":"Eur J Haematol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0609.1992.tb00569.x","article-title":"Long-term survival in acute lymphoblastic leukaemia in adults: a prospective study of 51 patients. Finnish Leukaemia Group","volume":"48","author":"Listed","year":"1992","journal-title":"Eur J Haematol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00043426-200110000-00004","article-title":"Childhood acute lymphoblastic leukemia: prognostic value of initial peripheral blast count in good responders to prednisone","volume":"23","author":"Felice","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-2001-16848","article-title":"Clinical outcome of patients with childhood acute lymphoblastic, leukaemia and an initial leukaemic blood blast count of less than 1000 per, microliter","volume":"213","author":"Lauten","year":"2001","journal-title":"Klin P\u00e4diatr"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1054\/bjoc.2000.1504","article-title":"Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)","volume":"83","author":"Donadieu","year":"2000","journal-title":"Br J Cancer"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","article-title":"CD45: a critical regulator of signaling thresholds in immune cells","volume":"21","author":"Hermiston","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35053086","article-title":"CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling","volume":"409","author":"Irie-Sasaki","year":"2001","journal-title":"Nature"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/87687","article-title":"CD45: new jobs for an old acquaintance","volume":"2","author":"Penninger","year":"2001","journal-title":"Nat Immunol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cellsig.2009.10.003","article-title":"Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45","volume":"22","author":"Saunders","year":"2010","journal-title":"Cell Signal"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood.V89.11.3960","article-title":"Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. a Pediatric Oncology Group study","volume":"89","author":"Borowitz","year":"1997","journal-title":"Blood"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3324\/haematol.2013.090225","article-title":"High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol","volume":"99","author":"Cario","year":"2014","journal-title":"Haematologica"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1182\/blood-2011-09-379958","article-title":"Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia","volume":"119","author":"Porcu","year":"2012","journal-title":"Blood"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2141.1991.tb08004.x","article-title":"Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance","volume":"79","author":"Cantu Rajnoldi","year":"1991","journal-title":"Br J Haematol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/mpo.2950210506","article-title":"Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia","volume":"21","author":"Fink","year":"1993","journal-title":"Med Pediatr Oncol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-642-84895-7_24","article-title":"Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86","volume":"131","author":"Ludwig","year":"1993","journal-title":"Recent Results Cancer Res"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood.V78.5.1327.1327","article-title":"Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse","volume":"78","author":"Pui","year":"1991","journal-title":"Blood"},{"key":"R44-20250504","first-page":"28","article-title":"Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"90","author":"Uckun","year":"1997","journal-title":"Blood"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM199103213241204","article-title":"Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood","volume":"324","author":"Wiersma","year":"1991","journal-title":"N Engl J Med"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.leu.2402021","article-title":"Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experience","volume":"15","author":"Campana","year":"2001","journal-title":"Leukemia"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MOH.0b013e3283543d5c","article-title":"Minimal residual disease monitoring in childhood acute lymphoblastic leukemia","volume":"19","author":"Campana","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1470-2045(15)70082-3","article-title":"Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study","volume":"16","author":"Pui","year":"2015","journal-title":"Lancet Oncol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.leu.2401364","article-title":"A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection","volume":"13","author":"Weir","year":"1999","journal-title":"Leukemia"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1182\/blood-2012-06-379040","article-title":"Has MRD monitoring superseded other prognostic factors in adult ALL","volume":"120","author":"Br\u00fcggemann","year":"2012","journal-title":"Blood"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study","volume":"111","author":"Borowitz","year":"2008","journal-title":"Blood"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/pbc.25582","article-title":"End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia","volume":"62","author":"Parekh","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2011-03-338707","article-title":"Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study","volume":"118","author":"Schrappe","year":"2011","journal-title":"Blood"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12887-015-0390-z","article-title":"Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China","volume":"15","author":"Wei","year":"2015","journal-title":"BMC Pediatr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:31:30Z","timestamp":1746340290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024518","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"2020-06-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}